# Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparative-efficacy-of-ceritinib-and-crizotinib-as-initial-alk-targeted/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniel Shao-Weng Tan,António Araújo,Jie Zhang,James Signorovitch,Zheng‐Yi Zhou,Xiaopeng Cai,Geoffrey Liu |
| Citations | 48 |
| DOI | 10.1016/j.jtho.2016.05.029 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086416305044/pdf |
| OpenAlex ID | https://openalex.org/W2415409512 |
| PMID | 27288979 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Zheng‐Yi Zhou](https://scholariq.org/researchers/zheng-yi-zhou/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.